Springer Nature’s Editorial and Publication Strategies for the SDGs
Sponsored by Springer Nature
Recorded on 05/15/2024
Posted in The Authority File
Episode 382
In the second episode of this four-part series, Ritu Dhand, Chief Scientific Officer at Springer Nature, digs into Springer Nature’s editorial and publication strategies that support the UN’s Sustainable Development Goals (SDGs). Aiming to create community and collaboration around the Goals, Springer has introduced initiatives to make SDG content more discoverable and fit the modern scholar’s needs. Mobile-friendly online platforms, lay summaries appropriate for interdisciplinary scholarship, and frequently updated live references buttress this work. Ritu also explains the business factors that went into Springer’s adoption of the SDGs and the sustainable publishing practices implemented internally. Last, she shares the range of conferences, webinars, white papers, and content hubs available from a customer point of view that underpin SDG publishing and awareness.
Our guest:

Ritu Dhand, PhD
Chief Scientific Officer
Springer Nature
Ritu Dhand was appointed Chief Scientific Officer, Springer Nature in January 2022. In this role, she is responsible for championing, promoting, and driving editorial excellence across the Springer Nature Journals Portfolio. Her remit also includes oversight of the Springer Nature SDG programme ensuring the research that has the potential to help achieve the Goals is accessible, published and has the attention of those best placed to implement it.
Previous to this role, Ritu was the Vice President, Nature Journals where she oversaw the editorial strategy and management of Nature, Nature Communications, and the Nature Research and Review Journals. Ritu joined Nature in January 1999 as the cancer and signalling editor and was promoted to the Chief Biological Sciences Editor, Nature in 2001 where she had oversight over content and managed the Nature life Sciences team for 13 years. Prior to that, she spent over 10 years studying cancer at PhD & post-doctoral level in research institutes within UCL and the Mount Sinai Hospital in Toronto, Canada.
